 The rapid development of coronavirus disease 2019, COVID-19 vaccines has not been met with an effective and equitable global distribution mechanism. This has led to low-income countries being particularly vulnerable due to high costs and supply shortages. In addition, parallel bilateral agreements have further exacerbated the situation by creating a system of vaccine nationalism which has led to hoarding of vaccines and unequal access to them. Furthermore, there is evidence of discrimination against certain groups within countries as well as a lack of preparedness for mass vaccination campaigns in many countries. To address these issues, pharmaceutical companies must share their technologies to increase supply and reduce prices, governments must prioritize equitable distribution to the most at-risk populations in all nations, and low-income countries must strengthen their logistical capacity in preparation for mass vaccination campaigns. This article was authored by Agnes Ben Aguajo, Ketis Mithuos, and Sheila Davis. We're article.tv, links in the description below.